|
Abbott Launches New Psoriasisanswers.com Web site
|
13 August 2010 |
|
Abbott Reports Strong Second Quarter Results
|
21 July 2010 |
|
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix
|
17 June 2010 |
|
Americans Are Not Taking Action to Protect Themselves Against Muscle Loss
|
10 June 2010 |
|
Abbott to Become No. 1 Pharmaceutical Company in India
|
21 May 2010 |
|
RA.com Features Interactive Resource to Help People Living with Rheumatoid Arthritis
|
14 May 2010 |
|
Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets
|
12 May 2010 |
|
Despite Concern, Americans Aren't Protecting Themselves Against Diabetes
|
28 April 2010 |
|
Abbott Reports Strong First Quarter Results
|
21 April 2010 |
|
Abbott Completes Acquisition of STARLIMS Technologies
|
23 March 2010 |
|
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
|
15 March 2010 |
|
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
|
10 March 2010 |
|
Initiation of Phase 2 Clinical Trial Investigating Three Individual HCV Antivirals
|
03 March 2010 |
|
Abbott Completes Acquisition of Solvay Pharmaceuticals
|
16 February 2010 |
|
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir® (ritonavir) Tablets
|
15 February 2010 |
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter
|
28 January 2010 |
|
Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts
|
20 January 2010 |
|
Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti
|
14 January 2010 |
|
Abbott's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide
|
11 January 2010 |
|
Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
|
15 December 2009 |